We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+4.94%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.35B
AUM Growth
+$25.5M
Cap. Flow
+$32.7M
Cap. Flow %
2.42%
Top 10 Hldgs %
12.05%
Holding
2,121
New
584
Increased
441
Reduced
528
Closed
563

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$97.8M
2
AAPL icon
Apple
AAPL
+$7.77M
3
COST icon
Costco
COST
+$6.63M
4
FRO icon
Frontline
FRO
+$5.7M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$5.47M

Top Sells

Rank Stock Value
1
LMND icon
Lemonade
LMND
+$4.64M
2
MGNI icon
Magnite
MGNI
+$3.66M
3
RELY icon
Remitly
RELY
+$3.66M
4
MNRO icon
Monro
MNRO
+$3.65M
5
VGR
Vector Group Ltd.
VGR
+$3.32M

Sector Composition

Rank Sector Weight
1 Technology 16.19%
2 Healthcare 13.13%
3 Financials 12.64%
4 Consumer Discretionary 12.16%
5 Industrials 9.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OUST icon
1301
Ouster
OUST
$2.92B
$253K 0.02%
20,727
-91,344
-82% -$803K
PLUS icon
1302
ePlus
PLUS
$2.34B
$253K 0.02%
+3,425
New +$299K
SPSC icon
1303
SPS Commerce
SPSC
$2.64B
$253K 0.02%
+1,374
New +$258K
CAPR icon
1304
Capricor Therapeutics
CAPR
$237M
$252K 0.02%
+18,243
New +$320K
CELC icon
1305
Celcuity
CELC
$4.52B
$252K 0.02%
+19,235
New +$271K
HCKT icon
1306
Hackett Group
HCKT
$287M
$252K 0.02%
8,209
-13,032
-61% -$376K
MCK icon
1307
McKesson
MCK
$101B
$252K 0.02%
+443
New +$248K
MYO icon
1308
Myomo
MYO
$56.2M
$252K 0.02%
39,070
-64,272
-62% -$313K
KMX icon
1309
CarMax
KMX
$8.26B
$251K 0.02%
+3,065
New +$241K
ANSS
1310
DELISTED
Ansys
ANSS
$250K 0.02%
741
-675
-48% -$226K
APLS
1311
DELISTED
Apellis Pharmaceuticals
APLS
$250K 0.02%
7,835
-20,749
-73% -$624K
FSLR icon
1312
First Solar
FSLR
$26.9B
$250K 0.02%
1,420
+24
+2% +$4.78K
NGNE icon
1313
Neurogene
NGNE
$712M
$250K 0.02%
+10,936
New +$407K
GFF icon
1314
Griffon
GFF
$4.86B
$248K 0.02%
+3,477
New +$252K
BEN icon
1315
Franklin Resources
BEN
$17.2B
$247K 0.02%
12,150
-9,525
-44% -$201K
MRNA icon
1316
Moderna
MRNA
$23.6B
$247K 0.02%
5,944
+302
+5% +$14.4K
EG icon
1317
Everest Group
EG
$14.4B
$245K 0.02%
+677
New +$254K
ETWO
1318
DELISTED
E2open Parent Holdings
ETWO
$245K 0.02%
92,183
+53,312
+137% +$168K
IRM icon
1319
Iron Mountain
IRM
$36.1B
$245K 0.02%
+2,329
New +$274K
ARQ icon
1320
Arq
ARQ
$89.3M
$245K 0.02%
+32,333
New +$213K
FVRR icon
1321
Fiverr
FVRR
$339M
$244K 0.02%
+7,693
New +$223K
KNTK icon
1322
Kinetik
KNTK
$7.98B
$243K 0.02%
+4,284
New +$232K
TDC icon
1323
Teradata
TDC
$2.55B
$243K 0.02%
7,790
-4,497
-37% -$141K
CRL icon
1324
Charles River Laboratories
CRL
$12.8B
$242K 0.02%
+1,310
New +$252K
CSGS
1325
DELISTED
CSG Systems International
CSGS
$242K 0.02%
4,726
+429
+10% +$22.1K
51 52
53
54 55

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q4 2024 Portfolio in Review

As of Q4 2024, GSA Capital Partners held 2,121 positions worth $1.35B, up 1.9% from $1.32B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

GSA Capital Partners's Q4 2024 filing shows 584 new, 441 increased, 528 reduced and 563 closed positions. Its largest new stake was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M. The largest sale was Lemonade, an estimated $4.64M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

  • GSA Capital Partners's largest Q4 2024 buy was iShares Core S&P 500 ETF: 165,180 shares worth $97.2M.
  • GSA Capital Partners added most to Frontline in Q4 2024, an estimated $5.7M increase.
  • GSA Capital Partners's biggest Q4 2024 reduction was Lemonade, cutting an estimated $4.64M.
  • GSA Capital Partners fully exited Monro in Q4 2024, selling an estimated $3.65M.
  • GSA Capital Partners's ten largest holdings make up 12% of its $1.35B portfolio in Q4 2024.
  • GSA Capital Partners opened 584 new positions and closed 563 in Q4 2024.
  • GSA Capital Partners's portfolio value rose 1.9% quarter-over-quarter to $1.35B.

Based on GSA Capital Partners's 13F filing for Q4 2024, filed 7 Feb 2025.